AIM-HI Accelerator Fund Celebrates Yiviva’s Milestone Collaboration With Astrazeneca China, Furthering Technology Platforms For Multiple Cancers
AIM-HI Accelerator Fundis proud to celebrate a significant milestone in the journey of one of its esteemed portfolio companies, Yiviva. A clinical-stage platform biotechnology company, Yiviva has entered into a Memorandum of Understanding (MOU) with AstraZeneca China, a multinational biopharmaceutical…